Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002008200 | SCV002273201 | likely benign | not provided | 2024-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004043261 | SCV004929655 | uncertain significance | Inborn genetic diseases | 2024-01-23 | criteria provided, single submitter | clinical testing | The c.3478C>T (p.P1160S) alteration is located in exon 38 (coding exon 37) of the COL4A2 gene. This alteration results from a C to T substitution at nucleotide position 3478, causing the proline (P) at amino acid position 1160 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV002008200 | SCV005192220 | uncertain significance | not provided | criteria provided, single submitter | not provided |